CELU Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Celularity Inc (CELU) does not present a compelling buy opportunity for a beginner investor with a long-term strategy at this time. The lack of positive trading signals, weak financial performance, and absence of significant catalysts make it prudent to hold off on investing in this stock.
The MACD is slightly positive but contracting, RSI is neutral at 38.354, and moving averages are converging, indicating no clear trend. The stock is trading near its support level of 1.22, with resistance at 1.339 and above. Overall, the technical indicators suggest a lack of strong momentum.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Gross margin also fell sharply by -64.94% YoY, indicating operational challenges. No recent congress trading data or analyst upgrades.
In Q3 2025, revenue dropped to $5.28M (-43.16% YoY), while net income improved to -$23.08M (+43.35% YoY). EPS improved to -0.88 (+20.55% YoY), but gross margin declined significantly to 19% (-64.94% YoY). Overall, financials indicate weak growth and profitability.
No data available for analyst ratings or price target changes.
